dr sun on tisotumab vedotin in recurrent or metastatic hnscc
Published 4 months ago • 66 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:03
dr sun on managing teaes of tisotumab vedotin in recurrent/metastatic hsncc
-
2:10
highlights on tisotumab vedotin 2l or 3l recurrent or metastatic cervical cancer: innovatv 301
-
0:57
dr. monk on the utility of tisotumab vedotin in recurrent cervical cancer
-
4:58
tisotumab vedotin for metastatic cervical cancer: results from esmo 2023 with brian slomovitz, md
-
0:57
dr. hong on the mechanism of action of tisotumab vedotin in cervical cancer
-
0:54
dr. hong on moving tisotumab vedotin to frontline therapy for cervical cancer
-
1:45
dr. hong on the safety profile of tisatumab vedotin in cervical cancer
-
0:55
dr. cohen on immunotherapy in head and neck squamous cell carcinoma
-
0:57
assessing the role of sunvozertinib in pretreated nsclc and in potential first-line usage
-
1:24
dr. santin on impact of trastuzumab in uterine serous carcinoma
-
1:06
dr. santin on rationale for trastuzumab in uterine serous carcinoma
-
1:00
patient case study - describe your history of sun exposure... - skin cancer surgeon dr. david sax
-
1:08
dr. james suen, otolaryngology, head and neck surgeon -- uams
-
0:52
the emerging role of t-cell engagers in sclc and neuroendocrine carcinomas
-
1:26
susan forsburg: imaging cancer cells
-
2:17
head & neck cancer with dr soffen
-
0:55
our calling: dr. patrick ha, head and neck oncologic surgeon